A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.
Authors say findings call for primary prevention strategies to extend beyond traditional 10-year estimates. (HealthDay News) — A single combined measure of high-sensitivity C-reactive protein (CRP), ...
Increased levels of lipoprotein(a), a variant of "bad cholesterol" in the bloodstream, are a risk factor for recurrent coronary heart disease (CHD) in people aged 60 or over, according to the results ...
Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular events in initially healthy women. Elevated plasma lipoprotein(a) is a ...
FERNANDINA BEACH, Fla., November 4, 2025 – The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RE ™ ...
Adults with a history of or at risk for a first atherosclerotic cardiovascular disease (ASCVD) event who received the oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor enlicitide ...
Lepodisiran is a long-duration small interfering RNA that inhibits hepatic production of apolipoprotein(a). New research findings on lepodisiran in patients with elevated lipoprotein(a) concentrations ...
DEAR DR. ROACH: I’m a healthy 50-year-old woman. I asked my doctor to test me for Lipoprotein(a) after reading about it. My level was high, at 41 mg/dL. My doctor told me that it didn’t need to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results